Publications & News

AltaThera Pharmaceuticals at HRS 2024

Chicago, IL – May 15, 2024 – AltaThera Pharmaceuticals will showcase its antiarrhythmic product, Sotalol IV, at the upcoming Heart Rhythm 2024 annual meeting in

AltaThera Pharmaceuticals at ACC.24

AltaThera Pharmaceuticals will showcase its antiarrhythmic product, Sotalol IV, at the upcoming American College of Cardiology 2024 annual meeting in Atlanta, Georgia from April 6-8. With attendees coming from around the world, ACC.24 provides an ideal venue to learn about the latest science and practice-changing updates in cardiovascular care.

AltaThera Pharmaceuticals at 29th Annual AF Symposium 2024

AltaThera Pharmaceuticals will be presenting its data at the 29th Annual AF Symposium at the Omni Boston at the Seaport from February 1-3. This intensive symposium brings together the world’s leading medical scientists to share recent advances in the field of atrial fibrillation.

AltaThera Pharmaceuticals at HRS 2024

Chicago, IL – May 15, 2024 – AltaThera Pharmaceuticals will showcase its antiarrhythmic product, Sotalol IV, at the upcoming Heart Rhythm 2024 annual meeting in

AltaThera Pharmaceuticals at ACC.24

AltaThera Pharmaceuticals will showcase its antiarrhythmic product, Sotalol IV, at the upcoming American College of Cardiology 2024 annual meeting in Atlanta, Georgia from April 6-8. With attendees coming from around the world, ACC.24 provides an ideal venue to learn about the latest science and practice-changing updates in cardiovascular care.

AltaThera Pharmaceuticals at 29th Annual AF Symposium 2024

AltaThera Pharmaceuticals will be presenting its data at the 29th Annual AF Symposium at the Omni Boston at the Seaport from February 1-3. This intensive symposium brings together the world’s leading medical scientists to share recent advances in the field of atrial fibrillation.